Published in Leukemia on May 01, 1997
Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia. Proc Natl Acad Sci U S A (2002) 1.16
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell (1984) 6.78
A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature (1982) 5.95
Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature (1984) 4.30
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet (1998) 3.91
Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature (1984) 3.24
RAG mutations in human B cell-negative SCID. Science (1996) 3.03
Regional mapping of the human immunoglobulin lambda light chain to the Philadelphia chromosome in chronic myeloid leukaemia. Leuk Res (1984) 2.44
Management of alimentary tract duplication in children. Br J Surg (1995) 2.26
A novel putative tyrosine kinase receptor with oncogenic potential. Oncogene (1991) 1.81
High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer (1989) 1.79
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting. Leukemia (2007) 1.79
Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood (1989) 1.74
Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL). Hematol Oncol Clin North Am (2000) 1.69
Isochromosome 17q in Ph1-negative leukemia: a clinical, cytogenetic, and molecular study. Blood (1990) 1.46
Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site. Oncogene (1997) 1.34
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood (1996) 1.33
Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification. Cancer Res (1993) 1.29
Polymerase chain reaction for detection of residual leukaemia. Lancet (1989) 1.28
Insufficient stocking of poisoning antidotes in hospital pharmacies. JAMA (1996) 1.27
Oncogenes: clues to carcinogenesis. Eur J Pediatr (1984) 1.25
The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7. Br J Haematol (1994) 1.24
Chromatid exchanges in ataxia telangiectasia, Bloom syndrome, Werner syndrome, and xeroderma pigmentosum. Ann Hum Genet (1976) 1.21
Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood. Blood (1993) 1.20
RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proc Natl Acad Sci U S A (1987) 1.20
bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia. Blood (1986) 1.14
Phenotypic and genotypic heterogeneity in infant acute leukemia. II. Acute nonlymphoblastic leukemia. Leukemia (1989) 1.10
Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32). Blood (2000) 1.09
C-abl and bcr are rearranged in a Ph1-negative CML patient. EMBO J (1985) 1.08
Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood (1991) 1.08
Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation. Blood (1999) 1.08
T cell receptor-CD3 complex during early T cell differentiation. Analysis of immature T cell acute lymphoblastic leukemias (T-ALL) at DNA, RNA, and cell membrane level. J Immunol (1987) 1.06
Is the chromosomal region 9q34 always involved in variants of the Ph1 translocation? Cancer Genet Cytogenet (1984) 1.06
Mapping of the oncogenes Myc, Sis, and int-1 to the distal part of mouse chromosome 15. Cytogenet Cell Genet (1987) 1.05
Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia. Cancer Res (1996) 1.04
Localization of the human c-sis oncogene in Ph1-positive and Ph1-negative chronic myelocytic leukemia by in situ hybridization. Blood (1984) 1.04
The proximal element of the beta globin locus control region is not functionally required in vivo. J Clin Invest (1991) 1.03
Clonal remissions in acute nonlymphocytic leukemia: evidence for a multistep pathogenesis of the malignancy. Blood (1991) 1.03
Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood (1995) 1.02
Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues. Cancer Res (1990) 1.02
Rapid and reliable detection of N-ras mutations in acute lymphoblastic leukemia by melting curve analysis using LightCycler technology. Leukemia (2000) 1.02
Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study. Leukemia (2006) 1.01
The murine ufo receptor: molecular cloning, chromosomal localization and in situ expression analysis. Oncogene (1992) 1.01
Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course. Blood (2001) 1.00
Concurrent mutations in two different ras genes in acute myelocytic leukemias. Nucleic Acids Res (1987) 0.99
Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequences. Blood (1989) 0.97
Severe combined immunodeficiency (SCID) in man: B cell-negative (B-) SCID patients exhibit an irregular recombination pattern at the JH locus. J Exp Med (1991) 0.95
Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology. Cancer Res (2000) 0.94
Identification of a novel putative Ran-binding protein and its close homologue. Biochem Biophys Res Commun (2000) 0.93
Acute lymphoblastic leukemia of childhood: identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1. Blood (1996) 0.93
Allelotype analysis of childhood acute lymphoblastic leukemia. Cancer Res (1995) 0.93
An oncogenic fusion product of the phosphatidylinositol 3-kinase p85beta subunit and HUMORF8, a putative deubiquitinating enzyme. Oncogene (1998) 0.91
The fusion of TEL and ABL in human acute lymphoblastic leukaemia is a rare event. Br J Haematol (1995) 0.90
Risk/MRD adapted GMALL trials in adult ALL. Ann Hematol (2004) 0.90
TEL is one of the targets for deletion on 12p in many cases of childhood B-lineage acute lymphoblastic leukemia. Leukemia (1997) 0.90
SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia. Leukemia (1993) 0.90
Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia. Leukemia (1989) 0.89
Clonal variation in childhood acute lymphoblastic leukaemia at early and late relapse detected by analyses of phenotype and genotype. Eur J Pediatr (1988) 0.89
P53 mutations in myelodysplastic syndromes. Leukemia (1992) 0.86
Spectrum of transforming sequences detected by tumorigenicity assay in a large series of human neoplasms. Int J Cancer (1999) 0.86
Methylation analysis of asparagine synthetase gene in acute lymphoblastic leukemia cells. Leukemia (2006) 0.86
Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia. Br J Haematol (1996) 0.86
Mutations of p53 in Wilms' tumors. Mod Pathol (1995) 0.85
Evolution of tumor cytogenetic aberrations and N-myc oncogene amplification in a case of disseminated neuroblastoma. Cancer Genet Cytogenet (1987) 0.85
Homozygous deletions at 9p21 in childhood acute lymphoblastic leukemia detected by microsatellite analysis. Leukemia (1997) 0.85
Prospective BCR-ABL analysis by polymerase chain reaction (RT-PCR) in adult acute B-lineage lymphoblastic leukemia: reliability of RT-nested-PCR and comparison to cytogenetic data. Leukemia (2001) 0.85
Germline configuration of nfkb2, c-rel and bcl3 in childhood acute lymphoblastic leukemia (ALL). Leukemia (1997) 0.85
Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the "BFM Family" Cooperative Group. Med Pediatr Oncol (1992) 0.85
Tandem duplication of the FLT3 gene in acute lymphoblastic leukemia: a marker for the monitoring of minimal residual disease. Leukemia (2000) 0.84
Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2/MTS1/INK4A), p18(INK4C) and p27(Kip1) genes in neuroblastomas. Cancer (1996) 0.84
Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment. Leukemia (2011) 0.84
The genomic structure of the human UFO receptor. Oncogene (1993) 0.84
Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms. Leukemia (1990) 0.83
High rate of chromosome abnormalities detected by fluorescence in situ hybridization using BCR and ABL probes in adult acute lymphoblastic leukemia. Leukemia (1998) 0.83
Amplification and expression of the N-myc gene in neuroblastoma. Eur J Pediatr (1987) 0.83
Molecular genetic analysis of DNA obtained from fixed, air dried or paraffin embedded sources. Ann Hematol (1991) 0.83
bcr Rearrangement without juxtaposition of c-abl in chronic myelocytic leukemia. J Exp Med (1985) 0.83
Analyses of phenotype and genotype in acute lymphoblastic leukemias at first presentation and in relapse. Blood (1987) 0.82
Rapid and non-radioactive prenatal diagnosis of beta thalassaemia and sickle cell disease: application of the polymerase chain reaction (PCR). Br J Haematol (1988) 0.82
Incidence of ras gene mutations in neuroblastoma. Eur J Pediatr (1988) 0.82
Essential thrombocythemia in two sisters originating from different stem cell levels. Blood (1990) 0.82
Duplex PCR facilitates the identification of immunoglobulin kappa (IGK) gene rearrangements in acute lymphoblastic leukemia. Leukemia (2000) 0.82
Rate of sister chromatid exchanges in Bloom syndrome fibroblasts reduced by co-cultivation with normal fibroblasts. Am J Hum Genet (1980) 0.82
Sister chromatid exchanges in a ring chromosome 4. Cytogenet Cell Genet (1977) 0.82
c-abl Oncogene and chromosome 22 "bcr" juxtaposition in chronic myelogenous leukemia. N Engl J Med (1985) 0.82
In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells. Blood (1992) 0.82
The ATM gene and susceptibility to childhood T-cell acute lymphoblastic leukaemia. Br J Haematol (1998) 0.82
Frequent loss of heterozygosity on the long arm of chromosome 6: identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia. Cancer Res (1998) 0.82
Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse. Leukemia (1992) 0.82
Expansion of a maternally derived monoclonal T cell population with CD3+/CD8+/T cell receptor-gamma/delta+ phenotype in a child with severe combined immunodeficiency. J Immunol (1991) 0.82
Acute leukemia with chromosome translocation (4;11): 7 new patients and analysis of 71 cases. Blut (1987) 0.82
Trisomy 14 in atypical chronic myeloid leukemia. Leukemia (1990) 0.81
Frequency of sister chromatid exchanges in Bloom syndrome fibroblasts reduced by cocultivation with normal cells. Hum Genet (1979) 0.81